Analyst Ratings for Royalty Pharma (RPRX)

RPRX Rating Summary

RPRX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on RPRX
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $52.38 (+19%) * Over Last 12-Mos
Rating Score: 5 / 10   Percentile Rank: 50%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/9/2020 UBS
» Updated 3/19/2021
Navin Jacob Upgrade Buy
(Neutral)
52.00
(51.00)
40.13
(44.02)
9.69% Details
7/14/2020 Evercore ISI Umer Raffat New Coverage In Line
(N/A)
N/A
(N/A)
47.64
(44.02)
-7.6% Details
Like RPRX Ratings? Also take a look at CNST, NERV, MOR, BHVN

RPRX Ratings News